“....its synthetic cannabidiol and its cannabinoid synthetic analog development assets.” - CBG?
”...other bacterial infections....” - bacterial pneumonia?
”....different routes of administration of the drug..” - via the lungs?
”...new uses for cannabinoids with improved bioavailability and potency.” - who knows?
All speculation of course but more interesting possibilities perhaps.
On the one hand it’s good to have several options and not be tied to one, on the other I wouldn’t want them to be spreading themselves too thin before getting more traction with some.
“....its synthetic cannabidiol and its cannabinoid synthetic...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |